Clinical Statements address topics of relevance to ophthalmologists and policy makers and state the Hoskins Center and Academy-approved position to educate and provide guidance on issues of concern. The Hoskins Center and Academy-approved clinical statements are developed without any external financial support. Authors and reviewers of Clinical Statements are volunteers and do not receive any financial compensation for their contributions to the documents.
Additional Policy and Information Statements developed by the Academy are available here. Downloading of Clinical Statements for personal use is permitted.
Reproduction or transmission of Clinical Statements, in electronic or print media, is expressly prohibited without written permission of the American Academy of Ophthalmology. To request permission to reproduce or reprint Clinical Statements or to link to this website, contact dmarchi@aao.org.
Direct all other inquiries regarding Clinical Statements to quality@aao.org.
|
|
Summary Recommendations for Keratorefractive Laser Surgery - June 2013
Summary recommendations for elective keratorefractive laser surgery based on expert opinion and consensus; promoting a patient's best interests and safety.
Date: June 2013
Source: AAO Quality of Care Secretariat, Hoskins Center for Quality Eye Care
Subspecialty:
Full Text
| PDF (171k)
Extended Wear of Contact Lenses - May 2013
Describes the risks associated with extended wear contact lenses and recommends patient education about good hygiene.
Date: May 2013
Source: AAO Quality of Care Secretariat, Hoskins Center for Quality Eye Care
Compendium Level: III
Subspecialty:
Full Text
| PDF (86k)
Protective Eyewear for Young Athletes - April 2013
A joint statement of the American Academy of Pediatrics (AAP) and the AAO that evaluates the role of protective eyewear in reducing the risk of sports-related eye injuries; providing eyewear recommendations for most sports.
Date: April 2013
Source: AAP, AAO Quality of Care Secretariat, Hoskins Center for Quality Eye Care
Compendium Level: III
Subspecialty:
Full Text
| PDF (119k)
Amblyopia is a Medical Condition - April 2013
A joint statement of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) and the AAO that describes amblyopia and the importance of proper medical treatment.
Date: April 2013
Source: AAPOS, AAO Quality of Care Secretariat, Hoskins Center for Quality Eye Care
Compendium Level: III
Subspecialty:
Full Text
| PDF (52k)
Adult Strabismus Surgery - April 2013
A joint statement of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) and the AAO that reviews the indications for surgical intervention in adult strabismus.
Date: April 2013
Source: AAPOS, AAO Quality of Care Secretariat, Hoskins Center for Quality Eye Care
Compendium Level: III
Subspecialty:
Full Text
| PDF (147k)
Screening Examination of Premature Infants for Retinopathy of Prematurity - January 2013
A joint Academy, AAP and AAPOS revised paper outlines the principles on which a screening program to detect ROP in infants at risk might be based and suggests guidelines for the United States.
Date: January 2013
Source: AAO, AAP, AAPOS and Hoskins Center for Quality Eye Care
Compendium Level: II
Subspecialty:
Full Text
| PDF (628k)
Drug Shortage: Non-preserved, Bisulfate-Free Epinephrine - December 2012
Non-preserved, bisulfate-free epinephrine is the basic component of the intracameral epi-Shugarcaine solution used for intraoperative floppy iris syndrome (IFIS) and pupil dilation. Earlier in 2012, American Regent, which was the sole source in United States for non-preserved, bisulfate-free epinephrine, suspended its manufacture of drug products. As of December 18 2012, this product is still not available from American Regent, although manufacturing has resumed and product is expected to be restocked but they have not issued a resupply date.
This clinical statement provides options for ophthalmologists to employ during this shortage, as well as links to check drug availability and resources on compounding pharmacies.
Date: December 2012
Subspecialty:
Full Text
| PDF (315k)
Recommendations for Genetic Testing of Inherited Eye Diseases: Report of the American Academy of Ophthalmology Task Force on Genetic Testing - November 2012
The Academy Task Force on Genetic Testing developed a statement to provide high level guidance on principles underlying the approach to genetic testing and the role of ophthalmologists in genetic testing.
Date: November 2012
Subspecialty:
Full Text
| PDF (134k)
Instrument-Based Pediatric Vision Screening Policy Statement - October 2012
A policy statement describing the use of automated vision screening technology (instrument-based vision screening) is presented. Screening for amblyogenic refractive error with instrument-based screening is not dependent on behavioral responses of children, as when visual acuity is measured. Instrument-based screening is quick, requires minimal cooperation of the child, and is especially useful in the preverbal, preliterate, or developmentally delayed child. Children younger than 4 years can benefit from instrument-based screening, and visual acuity testing can be used reliably in older children. Adoption of this new technology is highly dependent on third-party payment policies, which could present a significant barrier to adoption. Pediatrics 2012;130:983–986
Date: October 2012
Subspecialty:
Full Text
| PDF (195k)
Infection Prevention in Eye Care Services and Operating Areas and Operating Rooms - August 2012
Recommends minimum infection prevention guidelines and practices for the protection of patients, staff, and ophthalmologists in the ophthalmic care setting, drawing from current policies of the Centers for Disease Control and Prevention and other federal agencies.
Date: August 2012
Compendium Level: II
Subspecialty:
Full Text
| PDF (519k)
|
|
|
